The correct terminology for medical conditions can significantly impact diagnosis accuracy. Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), affects 1 in 8 women of reproductive age globally. Experts have renamed the disorder to better reflect the experiences of patients, as the former name contributed to confusion and delayed diagnoses.
PMOS is a complex condition that affects multiple body systems and presents differently in each patient. There is no single test for PMOS; diagnosis depends on a combination of symptoms and clinical findings. This variability can lead to challenges in identification, especially for healthcare providers who do not specialize in the condition.
Common symptoms such as acne and irregular periods may be mistaken for typical adolescent changes, further complicating diagnosis. Hormonal birth control can manage symptoms but may mask the underlying condition, leading to delayed recognition when patients stop taking it.
Treatment for PMOS is individualized, varying based on a patient's life stage and primary concerns. Misconceptions about PMOS include the belief that it is defined by ovarian cysts; the structures seen on the ovaries are immature follicles, not true cysts. Another myth is that only overweight individuals develop PMOS, while many patients with the condition are of normal weight.
PMOS is a polygenic disorder influenced by multiple genes, and while lifestyle changes can help manage symptoms, they do not cause or cure the condition. The syndrome can affect various body systems, increasing the risk of cardiovascular disease, insulin resistance, Type 2 diabetes, and sleep apnea. Mental health issues such as anxiety and depression are also more prevalent among those with PMOS.
Individuals experiencing symptoms like irregular periods, persistent acne, or excess hair should consult a healthcare provider. Care may involve various specialists, and patients are encouraged to ask broader questions about hormone levels and potential endocrine disorders.
PMOS is a lifelong condition that may not resolve after menopause. Ongoing monitoring and regular checkups are essential to prevent complications related to cardiovascular health and other chronic conditions. Jacquelyn Shaw, MD, a reproductive endocrinologist at NYU Langone Fertility Center, emphasizes the importance of early diagnosis and management of PMOS to improve health outcomes.